ANIP icon

ANI Pharmaceuticals
ANIP

Overview Fund Activity

134 hedge funds and large institutions have $241M invested in ANI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 26 closing their positions.

Holders
134
Holders Change
-7
Holders Change %
-4.96%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
42
Reduced
44
Closed
26
Calls
$2.02M
Puts
$2.08M
Net Calls
-$62K
Net Calls Change
-$2.24M

Top Buyers

1
TSW
1
Thompson Siegel & Walmsley
Virginia
$9.67M
2
Federated Hermes
2
Federated Hermes
Pennsylvania
$9.73M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$4.62M
4
Morgan Stanley
4
Morgan Stanley
New York
$4.51M
5
BlackRock
5
BlackRock
New York
$49.4M

Top Sellers

1
MP
1
Mangrove Partners
Connecticut
$0
2
First Manhattan
2
First Manhattan
New York
$0
3
HRCM
3
Hawk Ridge Capital Management
California
$0
4
Invesco
4
Invesco
Georgia
$2.49M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$5.61M
Name Holding Trade Value Shares
Change 		Shares
Change %
CTC
151
Central Trust Company
Missouri
– -$3K -75 Closed
AIC
152
Ameritas Investment Company
Nebraska
– -$2K -41 Closed
BCA
153
Berman Capital Advisors
Georgia
– -$1K -33 Closed
TFO
154
Tarbox Family Office
California
– -$1K -30 Closed
3 4 5 6
7